| Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979) |
|---|
| 09/12/2006 | US7105515 Such as N-[3-(2-diethylaminoethyl)-1H-indol-5-yl]-5-chloro-3-methylbenzo[b]thiophene-2-sulphonamide for treating anxiety, depression, cognitive memory disorders and senile dementia, psychosis, infant hyperkinesia (ADHD, attention deficit/hyperactivity disorder) |
| 09/12/2006 | US7105513 Cardiovascular disorders; strokes; hypotensive agents |
| 09/12/2006 | US7105509 Benzodiazepine derivatives as APP modulators |
| 09/12/2006 | US7105508 Integrin receptors antagonists |
| 09/12/2006 | US7105507 Cyclohexane derivatives and their use as therapeutic agents |
| 09/12/2006 | US7105505 Benzimidazole derivatives useful as histamine H3 antagonists |
| 09/12/2006 | US7105503 Pyrazole compounds |
| 09/12/2006 | US7105471 Arylphenyl-substituted cyclic ketoenols |
| 09/12/2006 | CA2307037C Oral pharmaceutical preparation comprising an antiulcer activity compound, and process for its production |
| 09/12/2006 | CA2251060C Acylated n-hydroxy methyl thalidomide prodrugs with immunomodulator action |
| 09/12/2006 | CA2241788C Novel n-(arylsulphonyl)amino acid derivatives, their preparation process and pharmaceutical compositions containing them |
| 09/12/2006 | CA2235986C Inhibitors of protein isoprenyl transferases |
| 09/12/2006 | CA2167004C Agent for treating mental disorders associated with cerebrovascular disorders |
| 09/11/2006 | CA2500676A1 Preparation of acid addition salts of amine bases by solid phase-gas phase reactions |
| 09/08/2006 | WO2006094237A2 Acridine and quinoline dervatives as sirtuin modulators |
| 09/08/2006 | WO2006094235A1 Fused heterocyclic compounds and their use as sirtuin modulators |
| 09/08/2006 | WO2006093677A1 Tetracyclic sulfonamide compounds and methods of use thereof |
| 09/08/2006 | WO2006093667A1 Tetracyclic amino and carboxamido compounds and methods of use thereof |
| 09/08/2006 | WO2006093339A1 Use of cinnamoyl compound |
| 09/08/2006 | WO2006093336A1 Use of cinnamoyl compound |
| 09/08/2006 | WO2006093253A1 Novel cyclic compound having quinolylalkylthio group |
| 09/08/2006 | WO2006093226A1 Antipruritic agent |
| 09/08/2006 | WO2006092599A2 Pyrrole derivatives as dna gyrase and topoisomerase inhibitors |
| 09/08/2006 | WO2006092579A1 Microcrystalline ( 5-fluoro-2-methyl-3-quinolin-2-ylmethyl-indol-1-yl) acetic acid |
| 09/08/2006 | WO2006092574A1 Indolylamino quinazoline derivatives as antitumor agents |
| 09/08/2006 | WO2006092573A1 Indazolylamino qionazoline derivatives as antitumor agents |
| 09/08/2006 | WO2006092422A1 Novel salts of 6-heterocyclyl substituted hexahydrophenanthridine derivatives |
| 09/08/2006 | WO2006092417A1 6 -heteroaryl-1, 2, 3,4,4a, 1ob-hexahydro-phenanthridines as pde-4 inhibitors for the treatment of inflammatory disorders |
| 09/08/2006 | WO2006092395A1 9-amino-acridine derivatives and their use for eliminating misfolded proteins |
| 09/08/2006 | WO2006071548A3 Aminopyrazine analogs for treating glaucoma and other rho kinase-mediated diseases |
| 09/08/2006 | WO2006063811A3 Substituted 1,2,4-triazin-5(2h)-ones |
| 09/08/2006 | WO2006055553A3 Novel m3 muscarinic acetylcholine receptor antagonists |
| 09/08/2006 | WO2006044497A3 Spiropiperidine compounds useful as beta-secretase inhibitors for the treatment of alzhermer’s disease |
| 09/08/2006 | WO2005086700A3 Hiv integrase inhibitors |
| 09/08/2006 | CA2600891A1 Microcrystalline ( 5-fluoro-2-methyl-3-quinolin-2-ylmethyl-indol-1-yl) acetic acid |
| 09/08/2006 | CA2600287A1 Use of cinnamoyl compound |
| 09/08/2006 | CA2599992A1 Acridine and quinoline dervatives as sirtuin modulators |
| 09/08/2006 | CA2599987A1 Fused heterocyclic compounds and their use as sirtuin modulators |
| 09/08/2006 | CA2598860A1 Novel salts of 6-heterocyclyl substituted hexahydrophenanthridine derivatives |
| 09/08/2006 | CA2598858A1 6 -heteroaryl-1, 2, 3,4,4a, 1ob-hexahydro-phenanthridines as pde-4 inhibitors for the treatment of inflammatory disorders |
| 09/08/2006 | CA2598647A1 Tetracyclic amino and carboxamido compounds and methods of use thereof |
| 09/08/2006 | CA2597576A1 Isoquinoline compounds and methods of use thereof |
| 09/07/2006 | US20060199964 preparation of 6-haloalkyl-3-nicotinic acid esters and also to novel enamine intermediates |
| 09/07/2006 | US20060199960 e.g. 6-Methyl-3-(pyridin-3-ylamino)-pyridine-2-carboxylic acid (4-methyl-thiazol-2-yl)-amide; metabotropic glutamate receptor antagonists (mGluR); central nervous system disorders, antidepressant, anxiolytc agent; psychosis, epilepsy, schizophrenia, Alzheimer's disease, cognitive disorders |
| 09/07/2006 | US20060199844 Inhibitors of raf-kinase; Hyperproliferative disorders |
| 09/07/2006 | US20060199840 Chemical derivatives and their application as antitelomerase agent |
| 09/07/2006 | US20060199835 Neuroprotective and anti-proliferative compounds |
| 09/07/2006 | US20060199827 Inhibitors of macrophage migration inhibitory factor and methods for identifying the same |
| 09/07/2006 | US20060199826 Cyclopropane compounds and pharmaceutical use thereof |
| 09/07/2006 | US20060199825 4-Aminating a 4-chloro-2-hydroxy-3-nitrodihydroquinoline with a N-(hetero)cyclylpiperazine, and alkylating the remaining amine group in the quinoline ring to produce a 4-(4-(hetero)cyclylpiperazinyl)-3-nitro-1-alkyldihydroquinolinone |
| 09/07/2006 | US20060199824 Treating or preventing pain, UI, an ulcer, IBD, IBS, an addictive disorder, Parkinson's disease, parkinsonism, anxiety, epilepsy, stroke, a seizure, a pruritic condition, psychosis, a cognitive disorder, a memory deficit, restricted brain function, Huntington's chorea, amyotrophic lateral sclerosis |
| 09/07/2006 | US20060199820 e.g. N1-hydroxy-N2-[(4-phenoxyphenyl)sulfonyl]-D-argininamide; metallopeptidase inhibitor; antiinflammation, anticarcinogenic, antidiabetic agent; angiogenesis inhibitor; atherosclerosis, stroke, ulcer, infertility, scleroderma, endometriosis, mesothelioma |
| 09/07/2006 | US20060199819 Inhibition of cyclooxygenase-2 activity |
| 09/07/2006 | US20060199818 Inhibiting the activity of a 5-hydroxytryptamine 2A by administering a N-heterocyclyl (preferably 1,3-dioxan-5-yl)-4-[(N-substituted)(hetero)arylamino]piperidine in which the N-substituant is arylalkanoyl, arylthioalkanoyl, arylalkylaminocarbonyl or arylalkylaminothiocarbonyl group |
| 09/07/2006 | US20060199815 NK1 antagonists |
| 09/07/2006 | US20060199813 Neurodegenerative diseases, psychological disorders; e.g. 1-[3-(4-Butyl-piperidin-1-yl)-propyl]-1,2,3,4-tetrahydroquinoline |
| 09/07/2006 | US20060199810 Neurodegenerative diseases, psychological disorders; e.g. 1-[3-(4-Butyl-piperidin-1-yl)-propyl]-1,2,3,4-tetrahydro-quinoline |
| 09/07/2006 | US20060199800 Pyrimidine compounds and pests controlling composition containing the same |
| 09/07/2006 | US20060199799 Benzimidazolidinone derivatives as muscarinic agents |
| 09/07/2006 | DE102005009909A1 Verbindungen geeignet zur Beseitigung fehlgefalteter Proteine Compounds suitable for the removal of misfolded proteins |
| 09/07/2006 | DE102005009705A1 Use of naphthalene derivatives for the treatment of hyperaldosteronism, heart failure, myocardial fibrosis, hypercortisolism and diabetes mellitus |
| 09/07/2006 | DE102005008412A1 New piperazine salt of omeprazol is proton pump inhibitor useful to prevent/treat e.g. peptic ulcer, gastritis, gastroesophageal reflux, acute stress ulcer or dyspepsia |
| 09/06/2006 | EP1698627A1 Pyrazole compounds useful as protein kinase inhibitors |
| 09/06/2006 | EP1698626A1 Amidopyrazole derivative |
| 09/06/2006 | EP1698375A1 Azetidine ring compounds and drugs comprising the same |
| 09/06/2006 | EP1698339A1 Neutrophilia inhibitor |
| 09/06/2006 | EP1697375A2 Heterocyclic protein kinase inhibitors and uses thereof |
| 09/06/2006 | EP1697351A1 2,6-bisheteroaryl-4-aminopyrimidines as adenosine receptor antagonists |
| 09/06/2006 | EP1697348A1 Hiv protease inhibiting compounds |
| 09/06/2006 | EP1697347A1 5- or 6-substituted benzimidazole derivatives as inhibitors of respiratiory syncytial virus replication |
| 09/06/2006 | EP1697346A1 Crystalline form of 2-{ 4-[3-(4-chloro-2-fluorophenyl)-4-pyrimidin-4-yl-1h-pyrazol-5-yl]piperidin-1-yl} -2-oxoethanol |
| 09/06/2006 | EP1697345A1 Morpholinyl containing benzimidazoles as inhibitors of respiratory syncytial virus replication |
| 09/06/2006 | EP1697344A2 Hiv protease inhibiting compounds |
| 09/06/2006 | EP1697343A1 Aminobenzimidazoles and benzimidazoles as inhibitors of respiratory syncytial virus replication |
| 09/06/2006 | EP1697342A2 Dipeptidyl peptidase inhibitors |
| 09/06/2006 | EP1697327A1 Insecticidal spiroindane derivatives |
| 09/06/2006 | EP1697319A1 Pyrrole compounds |
| 09/06/2006 | EP1697318A1 Prolinylarylacetamides |
| 09/06/2006 | EP1697312A2 Hydroxamic acid esters and pharmaceutical use thereof |
| 09/06/2006 | EP1697308A2 Phenylamide and pyridylamide beta-secretase inhibitors for the treatment of alzheimer s disease |
| 09/06/2006 | EP1697307A1 Opioid receptor antagonists |
| 09/06/2006 | EP1697292A1 Method for the production of tetrahydrogeranylacetone |
| 09/06/2006 | EP1696927A2 Mitotic kinesin inhibitors |
| 09/06/2006 | EP1696925A2 21-heterocyclic-4-azasteroid derivatives as androgen receptor modulators |
| 09/06/2006 | EP1696924A1 Acidic quinoline derivatives and their use for the prevention and/or treatment of hyperglycaemia-related pathologies |
| 09/06/2006 | EP1696919A2 3-cycloalkylaminopyrrolidine derivatives as modulators of chemokine receptors |
| 09/06/2006 | EP1696915A1 Benzenesulfonylamino-pyridin-2-yl derivatives and related compounds as inhibitors of 11-beta-hydroxysteroid dehydrogenase type 1 (11-beta-hsd-1) for the treatment of diabetes and obesity |
| 09/06/2006 | EP1572656A4 Compounds useful as pesticides |
| 09/06/2006 | EP1562935B1 Heteroaryloxy-substituted phenylaminopyrimidines as rho-kinase inhibitors |
| 09/06/2006 | EP1455579B1 Pyrazoles-pyrimidine fungicides |
| 09/06/2006 | CN1829711A Novel heterocyclic compounds useful for the treatment of inflammatory and allergic disorders: process for their preparation and pharmaceutical compositions containing them |
| 09/06/2006 | CN1829710A Process for preparing intermediates useful to prepare certain antibacterial N-formyl hydroxylamines |
| 09/06/2006 | CN1829709A Bicyclic imidazol derivatives against flaviviridae |
| 09/06/2006 | CN1829708A Piperidine compounds and pharmaceutical compositions containing them |
| 09/06/2006 | CN1829707A Cyano anthranilamide insecticides |
| 09/06/2006 | CN1829703A (Thio)carbamoyl-cyclohexane derivatives as D3/D2 receptor antagonists |
| 09/06/2006 | CN1829697A Aryl-heteroaromatic products, compositions containing same and use thereof |
| 09/06/2006 | CN1829517A Guanidino-substituted quinazolinone compounds as MC4-R agonists |
| 09/06/2006 | CN1829516A S 2-'4(phenylamino)-piperidin-1-yl!-n-phenyl-acetamine derivatives and related compounds as neuropeptide y5 (npy5) ligands for the treatement of obesity |
| 09/06/2006 | CN1829507A 酪氨酸激酶抑制剂 Tyrosine kinase inhibitor |